MXPA03010762A - Peptidos enlazantes de iap y ensayos para identificar los compuestos que enlazan el iap. - Google Patents

Peptidos enlazantes de iap y ensayos para identificar los compuestos que enlazan el iap.

Info

Publication number
MXPA03010762A
MXPA03010762A MXPA03010762A MXPA03010762A MXPA03010762A MX PA03010762 A MXPA03010762 A MX PA03010762A MX PA03010762 A MXPA03010762 A MX PA03010762A MX PA03010762 A MXPA03010762 A MX PA03010762A MX PA03010762 A MXPA03010762 A MX PA03010762A
Authority
MX
Mexico
Prior art keywords
iap
assays
binding peptides
bind
identifying compounds
Prior art date
Application number
MXPA03010762A
Other languages
English (en)
Inventor
Shi Yigong
Original Assignee
Univ Princeton
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Princeton filed Critical Univ Princeton
Publication of MXPA03010762A publication Critical patent/MXPA03010762A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/533—Production of labelled immunochemicals with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Genetics & Genomics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

Abstract

Se revelan ensayos para identificar pepticos y peptidomimeticos para promover la apoptosis en celulas, a traves de una trayectoria que incluye Inhibidor de Proteinas de Apoptosis (IAPs), ejemplificado por XIAP, y la proteina mitocondrial Smac/DIABOLO (en lo sucesivo Smac) y sus homologos. Tambien se revelan peptidomimeticos y peptidos enlazantes de IAP identificados a traves del uso del ensayo.
MXPA03010762A 2001-05-31 2002-05-31 Peptidos enlazantes de iap y ensayos para identificar los compuestos que enlazan el iap. MXPA03010762A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US29468201P 2001-05-31 2001-05-31
US34563002P 2002-01-03 2002-01-03
PCT/US2002/017342 WO2002096930A2 (en) 2001-05-31 2002-05-31 Iap binding peptides and assays for identifying compounds that bind iap

Publications (1)

Publication Number Publication Date
MXPA03010762A true MXPA03010762A (es) 2005-03-07

Family

ID=26968661

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03010762A MXPA03010762A (es) 2001-05-31 2002-05-31 Peptidos enlazantes de iap y ensayos para identificar los compuestos que enlazan el iap.

Country Status (6)

Country Link
US (1) US20050176649A1 (es)
EP (1) EP1421204A4 (es)
JP (1) JP2004531731A (es)
CA (1) CA2449168A1 (es)
MX (1) MXPA03010762A (es)
WO (1) WO2002096930A2 (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003040172A2 (en) * 2001-11-09 2003-05-15 Aegera Therapeutics, Inc. Methods and reagents for peptide-bir interaction screens
DE60322120D1 (de) * 2003-02-07 2008-08-21 Genentech Inc Zusammensetzungen und verfahren für verstärkte apoptose
US20080199439A1 (en) * 2003-02-12 2008-08-21 Mclendon George L IAP-binding cargo molecules and peptidomimetics for use in diagnostic and therapeutic methods
WO2005069888A2 (en) * 2004-01-16 2005-08-04 The Regents Of The University Of Michigan Smac peptidomimetics and the uses thereof
WO2005084317A2 (en) * 2004-03-01 2005-09-15 Board Of Regents, The University Of Texas System Dimeric small molecule potentiators of apoptosis
AU2005228950B2 (en) 2004-03-23 2012-02-02 Genentech, Inc. Azabicyclo-octane inhibitors of IAP
KR100984459B1 (ko) 2004-07-02 2010-09-29 제넨테크, 인크. Ｉａｐ의 억제제
AU2005274937B2 (en) * 2004-07-15 2011-08-18 Medivir Ab IAP binding compounds
JP5007235B2 (ja) 2004-12-20 2012-08-22 ジェネンテック， インコーポレイテッド Ｉａｐのピロリジンインヒビター
CN101128425B (zh) * 2005-02-25 2012-12-26 泰特拉洛吉克药业公司 Iap二聚体抑制剂
KR101317661B1 (ko) 2005-02-25 2013-10-15 테트랄로직 파마슈티칼스 코포레이션 이량체성 ｉａｐ 억제제
CA2607940C (en) 2005-05-18 2009-12-15 Aegera Therapeutics Inc. Bir domain binding compounds
US8318717B2 (en) 2005-05-25 2012-11-27 2Curex Compounds modifying apoptosis
WO2006128455A2 (en) * 2005-05-25 2006-12-07 2Curex Aps Compounds modifying apoptosis
WO2007038876A1 (en) 2005-10-04 2007-04-12 Inimex Pharmaceuticals Inc. Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity
WO2007048224A1 (en) 2005-10-25 2007-05-03 Aegera Therapeutics Inc. Iap bir domain binding compounds
NZ594746A (en) 2005-12-19 2013-03-28 Genentech Inc Inhibitors of iap
TWI504597B (zh) 2006-03-16 2015-10-21 Pharmascience Inc 結合於細胞凋亡抑制蛋白（ｉａｐ）之桿狀病毒ｉａｐ重複序列（ｂｉｒ）區域之化合物
EP2049524A2 (en) 2006-07-24 2009-04-22 Tetralogic Pharmaceuticals Corporation Iap inhibitors
EP2049563B1 (en) 2006-07-24 2014-03-12 Tetralogic Pharmaceuticals Corporation Dimeric iap antagonists
RU2466131C2 (ru) 2006-12-19 2012-11-10 Дженентек, Инк. Имидазопиридиновые ингибиторы iap
US8907092B2 (en) 2007-04-30 2014-12-09 Genentech, Inc. Inhibitors of IAP
CN102171209A (zh) 2008-08-02 2011-08-31 健泰科生物技术公司 Iap抑制剂
US8283372B2 (en) 2009-07-02 2012-10-09 Tetralogic Pharmaceuticals Corp. 2-(1H-indol-3-ylmethyl)-pyrrolidine dimer as a SMAC mimetic
MX2012009388A (es) 2010-02-11 2012-10-01 Univ Northwestern Moduladores del receptor de n-metil-d-aspartato estabilizado de estructura secundaria y sus usos.
KR101692275B1 (ko) * 2010-02-11 2017-01-04 노오쓰웨스턴 유니버시티 ２차 구조 안정화된 ｎｍｄａ 수용체 조절제 및 그의 용도
SG182724A1 (en) 2010-02-12 2012-08-30 Pharmascience Inc Iap bir domain binding compounds
EP2864528A1 (en) * 2012-06-25 2015-04-29 Silicor Materials Inc. Lining for surfaces of a refractory crucible for purification of silicon melt and method of purification of the silicon melt using that crucible
KR102302971B1 (ko) * 2020-04-24 2021-09-15 성신여자대학교 연구 산학협력단 활성 기반 htra 검출용 테트라 펩타이드 프로브

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5698448A (en) * 1988-12-02 1997-12-16 Soldin; Steven J. Immunosuppressive drug binding proteins and use
US6187557B1 (en) * 1995-08-08 2001-02-13 Tularik Inc. c-IAP1 and c-IAP2: inhibitors of apoptosis
US5786173A (en) * 1996-03-19 1998-07-28 Idun Pharmaceuticals, Inc. MCH4 and MCH5, apoptotic protease, nucleic acids encoding and methods of use
ATE398459T1 (de) * 1996-04-26 2008-07-15 Univ Ottawa Verwendung von naip oder iap für die behandlung und vorbeugung von neuronalen erkrankungen
US5977311A (en) * 1997-09-23 1999-11-02 Curagen Corporation 53BP2 complexes
US6110691A (en) * 2000-01-06 2000-08-29 Board Of Regents, The University Of Texas System Activators of caspases
US6608026B1 (en) * 2000-08-23 2003-08-19 Board Of Regents, The University Of Texas System Apoptotic compounds
CA2420534A1 (en) * 2000-08-24 2002-02-28 Thomas Jefferson University An iap binding peptide or polypeptide and methods of using the same
US6992063B2 (en) * 2000-09-29 2006-01-31 The Trustees Of Princeton University Compositions and method for regulating apoptosis
AU2001293189A1 (en) * 2000-09-29 2002-04-08 Trustees Of Princeton University Compositions and methods for regulating apoptosis
US20020160975A1 (en) * 2001-02-08 2002-10-31 Thomas Jefferson University Conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO for mediating apoptosis

Also Published As

Publication number Publication date
EP1421204A2 (en) 2004-05-26
WO2002096930A2 (en) 2002-12-05
CA2449168A1 (en) 2002-12-05
EP1421204A4 (en) 2004-12-15
JP2004531731A (ja) 2004-10-14
US20050176649A1 (en) 2005-08-11
WO2002096930A3 (en) 2004-03-18

Similar Documents

Publication Publication Date Title
MXPA03010762A (es) Peptidos enlazantes de iap y ensayos para identificar los compuestos que enlazan el iap.
ATE415413T1 (de) Iap-bindende verbindungen
DK1084146T3 (da) Hybridprotein til inhibering af degranuleringen af mastocyter og anvendelse deraf
DE60330541D1 (de) System zum Verfolgen von Poststücken
AU2003249920A1 (en) Peptide inhibitors of smac protein binding to inhibitor of apoptosis proteins (iap)
DE602006018424D1 (de) Peptide zum nachweis von ehrlichia ewingii antikörper
WO2006076687A3 (en) Elisa assays using prion-specific peptide reagents
WO2003074546A3 (de) Streptavidin-bindungspeptid
EP1576115A3 (en) Protein chips
AU2003229161A1 (en) Psp94 binding protein and psp94 diagnostic assays
EP1499635B8 (en) Teneurin c-terminal associated peptides (tcap) and uses thereof
AU2003205623A8 (en) Prion protein carrier-conjugates
WO2003010184A3 (en) A conserved xiap-interaction motif in caspase-9 and smac/diablo for mediating apoptosis
AU2001261408A1 (en) Mapping molecular interactions in plants with protein fragments complementation assays
NO20044186L (no) Peptid-deformylaseinhibitorer
AU2003220217A1 (en) Identifying peptide modifications
ATE433953T1 (de) Peptiddeformylaseinhibitoren
WO2003087145A3 (en) Purified polypeptides involved in quorum sensing
WO2004110243A3 (en) COMPOSITIONS AND METHODS FOR ENHANCING THE IDENTIFICATION OF PRION PROTEIN PRPsc
AU2003280316A1 (en) Zymogen-like protein c polypeptides
AU2003235099A1 (en) Novel proteins and dnas encoding the same
SI1941867T1 (sl) Polipeptid z modificirano Kunitzovo domeno
EP1315752A4 (en) MODIFIED PROTEINS, NOVEL ISOLATED PEPTIDES AND USE THEREOF
WO2002012274A3 (en) Iapl-3 a protein inhibitor of apoptosis proteins
AU2003227426A1 (en) Novel proteins and dnas encoding the same

Legal Events

Date Code Title Description
FA Abandonment or withdrawal